Bullous pemphigoid is a rare autoimmune disease that affects your skin. It’s a chronic disease that causes itchy, fluid-filled blisters to form all over your body. Although people of all ages, ...

Bullous pemphigoid (BP) is an autoimmune disorder that mainly affects older adults. The condition causes your immune system to attack proteins that hold the layers of your skin together. This damages ...

This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals. In this module, you will master the immunopathology of bullous pemphigoid (BP) and its disease burden. In ...

Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant plasma-cell disorder present in approximately 5% of the general population over the age of 50 years. MGUS is characterized ...

The age of onset is typically between 60–80 years (Fitzpatrick et al., 2008). The risk for the disease increases 300 fold for patients 90 years of age or older compared to risk for patients 60 years ...

This is a rare autoimmune skin disorder that occurs when your immune system starts attacking healthy epidermis cells (the top layer of your skin). Pemphigus can manifest itself as blisters and sores ...

Charo's husband Kjell Rasten was suffering from bullous pemphigoid prior to his death Julie Mazziotta is the Senior Sports Editor at PEOPLE, covering everything from the NFL to tennis to Simone Biles ...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid. The approval is based on results from the pivotal ADEPT phase 2/3 ...

A Prescription Drug User Fee Act target date of June 20, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics ...

Patients with cancer often require specialised care at centres located far from their residence. During the COVID-19 pandemic, telemedicine has rapidly gained ground as a way to ease system pressures ...